Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "A04AA" (58)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Ondansetron (A04AA01) 38 products
WHO-DDD
DrugBank.ca
IP
CI
Ondansetron Spirig HC 4 mg
10
PR
PR
k.A.
Melting tablets: Ondansetronum 4 mg
Spirig HealthCare AG
B
FB
G
IP
Ondansetron Spirig HC 8 mg
6
PR
PR
k.A.
Melting tablets: Ondansetronum 8 mg
Spirig HealthCare AG
B
FB
G
IP
Ondansetron Spirig HC 8 mg
10
PR
PR
k.A.
Melting tablets: Ondansetronum 8 mg
Spirig HealthCare AG
B
FB
G
L
IP
CI
Zofran 4 mg/2 mL
5 x 2 ml
41.61
61.00
20 %
Concentrate for infusion: Ondansetronum 4mg / 2ml
Sandoz
Pharmaceuticals AG
B / SL / SO
FB
G
L
IP
CI
Zofran 4 mg/2 mL
10 x 2 ml
83.22
105.60
20 %
Concentrate for infusion: Ondansetronum 4mg / 2ml
Sandoz
Pharmaceuticals AG
B / SL / SO
FB
G
L
IP
CI
Zofran 8 mg/4 mL
5 x 4 ml
76.73
98.70
20 %
Concentrate for infusion: Ondansetronum 8mg / 4ml
Sandoz
Pharmaceuticals AG
B / SL / SO
FB
G
L
IP
CI
Zofran 8 mg/4 mL
8 x 4 ml
122.77
148.05
20 %
Concentrate for infusion: Ondansetronum 8mg / 4ml
Sandoz
Pharmaceuticals AG
B / SL / SO
FB
G
L
IP
CI
Zofran 4 mg
10 Tablet(s)
26.59
45.05
20 %
Coated tablets: Ondansetronum 4 mg
Sandoz
Pharmaceuticals AG
B / SL / SO
FB
G
L
IP
CI
Zofran 8 mg
6 Tablet(s)
26.68
45.10
20 %
Coated tablets: Ondansetronum 8 mg
Sandoz
Pharmaceuticals AG
B / SL / SO
FB
G
L
IP
CI
Zofran Zydis 4 mg
-
T
10 Tablet(s)
26.59
45.05
20 %
Zydis Lingualtabletten: Ondansetronum 4 mg
Sandoz
Pharmaceuticals AG
B / SL / SO
FB
G
L
IP
CI
Zofran Zydis 8 mg
‐
I
-
T
6 Tablet(s)
26.68
45.10
20 %
Zydis Lingualtabletten: Ondansetronum 8 mg
Sandoz
Pharmaceuticals AG
B / SL / SO
FB
G
L
IP
CI
Ondansetron ODT Labatec 4 mg
10 Tablet(s)
22.60
40.95
10 %
Melting tablets: Ondansetronum 4 mg
Labatec Pharma SA
B / SL / SG
FB
G
L
IP
CI
Ondansetron ODT Labatec 8 mg
6 Tablet(s)
22.61
40.95
10 %
Melting tablets: Ondansetronum 8 mg
Labatec Pharma SA
B / SL / SG
FB
G
L
IP
CI
CM
Ondansetron ODT Sandoz 4 mg
10
22.60
40.95
10 %
Melting tablets: Ondansetronum 4 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CM
Ondansetron ODT Sandoz 8 mg
6
22.61
40.95
10 %
Melting tablets: Ondansetronum 8 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Ondansetron-Teva 4 oro
10 Tablet(s)
22.60
40.95
10 %
Melting tablets: Ondansetronum 4 mg
Teva Pharma AG
B / SL / SG
FB
G
L
IP
CI
Ondansetron-Teva 8 oro
6 Tablet(s)
22.61
40.95
10 %
Melting tablets: Ondansetronum 8 mg
Teva Pharma AG
B / SL / SG
FB
G
L
IP
Ondansetron Accord 8 mg/4 ml
5
57.55
79.00
10 %
Concentrate for infusion: Ondansetronum 8mg / 4ml
Accord Healthcare AG
B / SL / SG
FB
G
L
IP
Ondansetron Fresenius
i.v. 8 mg/4 ml
5 1 ampoule(s) à 4 ml
57.55
79.00
10 %
Concentrate for infusion: Ondansetronum 8mg / 4ml
Fresenius Kabi
(Schweiz) AG
B / SL / SG
FB
G
L
IP
Ondansetron Labatec,
4mg/2ml
5 1 ampoule(s) à 2 ml
30.90
50.00
10 %
Concentrate for infusion: Ondansetronum 4mg / 2ml
Labatec Pharma SA
B / SL / SG
FB
G
L
IP
Ondansetron Labatec,
8mg/4ml
5 1 ampoule(s) à 4 ml
57.55
79.00
10 %
Concentrate for infusion: Ondansetronum 8mg / 4ml
Labatec Pharma SA
B / SL / SG
FB
G
L
IP
Ondansetron-Teva 4mg/2ml
5 x 2 ml
30.86
50.00
10 %
Concentrate for infusion: Ondansetronum 4mg / 2ml
Teva Pharma AG
B / SL / SG
FB
G
L
IP
Ondansetron-Teva 8mg/4ml
5 x 4 ml
57.55
79.00
10 %
Concentrate for infusion: Ondansetronum 8mg / 4ml
Teva Pharma AG
B / SL / SG
FB
G
L
IP
CI
Ondansetron Labatec 4 mg
10 Tablet(s)
20.56
38.85
10 %
Coated tablets: Ondansetronum 4 mg
Labatec Pharma SA
B / SL / SG
FB
G
L
IP
CI
Ondansetron Labatec 8 mg
6 Tablet(s)
20.56
38.85
10 %
Coated tablets: Ondansetronum 8 mg
Labatec Pharma SA
B / SL / SG
FB
G
L
IP
CI
CM
Ondansetron Sandoz 4 mg
10
20.56
38.85
10 %
Coated tablets: Ondansetronum 4 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CM
Ondansetron Sandoz 8 mg
6
20.56
38.85
10 %
Coated tablets: Ondansetronum 8 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CI
Ondansetron-Teva, 4 mg
10 Tablet(s)
20.56
38.85
10 %
Coated tablets: Ondansetronum 4 mg
Teva Pharma AG
B / SL / SG
FB
G
L
IP
CI
Ondansetron-Teva, 8 mg
6 Tablet(s)
20.56
38.85
10 %
Coated tablets: Ondansetronum 8 mg
Teva Pharma AG
B / SL / SG
FB
G
L
IP
CM
Ondansetron Sandoz 4 mg/2 ml
5 x 2 ml
30.88
50.00
10 %
Infusionskonzentrat/ Injektionslösung: Ondansetronum 4mg / 2ml
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CM
Ondansetron Sandoz 4 mg/2 ml
10 x 2 ml
61.76
83.60
10 %
Infusionskonzentrat/ Injektionslösung: Ondansetronum 4mg / 2ml
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CM
Ondansetron Sandoz 8 mg/4 ml
5 x 4 ml
57.55
79.00
10 %
Infusionskonzentrat/ Injektionslösung: Ondansetronum 8mg / 4ml
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
CM
Ondansetron Sandoz 8 mg/4 ml
8 x 4 ml
92.08
116.55
10 %
Infusionskonzentrat/ Injektionslösung: Ondansetronum 8mg / 4ml
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
Ondansetron Accord 4 mg/2 ml
5
30.88
50.00
10 %
Konzentrat zur Herstellung einer Infusionslösung / Injektionslösung: Ondansetronum 4mg / 2ml
Accord Healthcare AG
B / SL / SG
FB
G
L
IP
Ondansetron Fresenius
i.v. 4 mg/2 ml
5 1 ampoule(s) à 2 ml
30.91
50.05
10 %
Konzentrat zur Herstellung einer Injektions- /Infusionslösung: Ondansetronum 4mg / 2ml
Fresenius Kabi
(Schweiz) AG
B / SL / SG
FB
G
IP
CI
Ondansetron ODT Labatec 4 mg
6 Tablet(s)
PR
PR
k.A.
Melting tablets: Ondansetronum 4 mg
Labatec Pharma SA
B
FB
G
IP
CI
Ondansetron ODT Labatec 8 mg
10 Tablet(s)
PR
PR
k.A.
Melting tablets: Ondansetronum 8 mg
Labatec Pharma SA
B
FB
G
IP
CI
Ondansetron Labatec 8 mg
10 Tablet(s)
PR
PR
k.A.
Coated tablets: Ondansetronum 8 mg
Labatec Pharma SA
B
FB
G
Granisetron (A04AA02) 13 products
WHO-DDD
DrugBank.ca
L
IP
Kytril, Konzentrat zur
Herstellung einer
Infusionslösung 3 mg
5 ampoule(s)
78.43
101.00
10 %
Granisetronum 3mg / 3ml
Atnahs Pharma
Switzerland AG
B / SL / SO
FB
G
L
IP
Kytril, Konzentrat zur
Herstellung einer
Infusionslösung 1 mg
5 ampoule(s)
34.05
53.15
10 %
Granisetronum 1 mg/ml
Atnahs Pharma
Switzerland AG
B / SL / SO
FB
G
L
IP
Granisetron Fresenius
i.v. 1mg/1ml
5 ampoule(s)
28.94
47.90
10 %
Concentrate for infusion: Granisetronum 1 mg/ml
Fresenius Kabi
(Schweiz) AG
B / SL / SG
FB
G
L
IP
Granisetron Fresenius
i.v. 3mg/3ml
5 ampoule(s)
66.67
88.90
10 %
Concentrate for infusion: Granisetronum 3mg / 3ml
Fresenius Kabi
(Schweiz) AG
B / SL / SG
FB
G
L
IP
CI
Kytril 1 mg
2 Tablet(s)
11.52
28.95
10 %
Coated tablets: Granisetronum 1 mg
Atnahs Pharma
Switzerland AG
B / SL
FB
G
L
IP
CI
Kytril 2 mg
Tablet(s)
11.52
28.95
10 %
Coated tablets: Granisetronum 2 mg
Atnahs Pharma
Switzerland AG
B / SL
FB
G
IP
CI
Kytril 1 mg
10 Tablet(s)
PR
PR
k.A.
Coated tablets: Granisetronum 1 mg
Atnahs Pharma
Switzerland AG
B
FB
G
IP
CI
Kytril 2 mg
5 Tablet(s)
PR
PR
k.A.
Coated tablets: Granisetronum 2 mg
Atnahs Pharma
Switzerland AG
B
FB
G
IP
Granisetron Labatec
1mg/ml
ampoule(s)
PR
PR
k.A.
Labatec Pharma SA
B
FB
G
IP
Granisetron Labatec
1mg/ml
5 ampoule(s)
PR
PR
k.A.
Labatec Pharma SA
B
FB
G
IP
Granisetron Labatec
3mg/3ml
ampoule(s)
PR
PR
k.A.
Labatec Pharma SA
B
FB
G
IP
Granisetron Labatec
3mg/3ml
5 ampoule(s)
PR
PR
k.A.
Labatec Pharma SA
B
FB
G
Kytril
Fertigspritze(n)
PR
PR
k.A.
Concentrate for infusion: 2 Active Agents
Roche Pharma
(Schweiz) AG
B
FB
G
Palonosetron (A04AA05) 5 products
WHO-DDD
DrugBank.ca
L
SIP
IP
Aloxi
Durchstechflasche(n)
47.97
68.15
10 %
Injection solution: Palonosetronum
Medius AG
B / SL / SO
FB
G
L
IP
Palonosetron Accord 0,25
mg/5 ml
40.77
60.75
10 %
Injection solution: Palonosetronum
Accord Healthcare AG
● 
B / SL / SG
FB
G
L
IP
Palonosetron-Teva 0.25
mg/5 ml
40.77
60.75
10 %
Injection solution: Palonosetronum
Teva Pharma AG
B / SL / SG
FB
G
L
IP
Palonosetron Labatec 0.25 mg/ 5 ml
40.77
60.75
10 %
solution injectable i.v.: Palonosetronum
Labatec Pharma SA
B / SL / SG
FB
G
L
IP
CI
Aloxi 500 Mikrogramm
Capsule(s)
62.47
84.35
10 %
capsule molle: Palonosetronum 500 µg
Medius AG
B / SL
FB
G
Palonosetron, Combinations (A04AA55) 2 products
WHO-DDD
DrugBank.ca
L
IP
Akynzeo IV 235 mg / 0.25 mg
77.72
100.95
10 %
Concentrate for infusion: 2 Active Agents
Medius AG
B / SL
FB
G
L
IP
CI
Akynzeo 300 mg/0.5 mg
Capsule(s)
81.24
104.75
10 %
Capsules: 2 Active Agents
Medius AG
B / SL
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home